Phase II study of R115777, a farnesyl transferase inhibitor, in myelodysplastic syndrome.
Kurzrock R, Albitar M, Cortes JE, Estey EH, Faderl SH, Garcia-Manero G, Thomas DA, Giles FJ, Ryback ME, Thibault A, De Porre P, Kantarjian HM.
Kurzrock R, et al.
J Clin Oncol. 2004 Apr 1;22(7):1287-92. doi: 10.1200/JCO.2004.08.082.
J Clin Oncol. 2004.
PMID: 15051776
Clinical Trial.